Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Meta’s own AI was exploited to hijack Instagram accounts

June 1, 2026

Saskatchewan receives D+ for addressing poverty

June 1, 2026

New documents show potential pipeline routes from Alberta to B.C.’s coast

June 1, 2026

Gemini’s new AI agent is about as good as Google’s demo

June 1, 2026

Best Early Stage Presale Opportunity: Pepe Dollar Shines Against PEPETO in Q3 2026

June 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » TIME Honors Vibrant’s Chronic Constipation Treatment Among 2023’s Best Inventions
Press Release

TIME Honors Vibrant’s Chronic Constipation Treatment Among 2023’s Best Inventions

By News RoomNovember 28, 20232 Mins Read
TIME Honors Vibrant’s Chronic Constipation Treatment Among 2023’s Best Inventions
Share
Facebook Twitter LinkedIn Pinterest Email

BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) — TIME has honored Vibrant, the groundbreaking drug-free treatment for chronic constipation by Vibrant Gastro, as part of its list of 2023’s Best Inventions.

Up to one in five American adults — disproportionately women and people of color — struggle to have bowel movements, and existing treatments ruin their quality of life. Traditional and prescription laxatives cause sudden on-set diarrhea — uncomfortable, uncontrollable and unpredictable. In fact, 60% of patients say the treatments are worse than the constipation itself.

“That’s not the case with the … Vibrant System — a prescription, non-pharmacological capsule programmed to vibrate eight to 10 hours after ingestion, when it reaches the large intestine,” writes TIME’s Katie MacBride. “The vibrations stimulate nerve cells involved in peristalsis, the process that pushes food through the digestive system. When the capsule’s work is done, it passes through the patient and is flushed away.”

Vibrant restores the colon’s natural rhythm and puts you back in control with consistent bowel movements at predictable times. Studies show that Vibrant has a low rate of side effects, with just 1.2% of patients reporting diarrhea. Since Vibrant is not a drug, there are no interactions with other drugs, unlike traditional and prescription laxatives.

“Being honored among TIME’s Best Inventions is further validation that Vibrant offers a real answer for the tens of millions of Americans whose lives are upended by chronic constipation,” said Vibrant Gastro CEO John Schellhorn. “The strong interest we’ve seen since Vibrant’s clearance by the FDA demonstrates how patients and physicians have long sought a real solution for a life-altering problem.”

About Vibrant
Up to 1 in 5 American adults — disproportionately women and people of color — struggle with chronic constipation and existing treatments ruin their quality of life with 60% saying the treatments, which cause diarrhea, are worse than the constipation. Vibrant is a new FDA-cleared drug-free treatment that uses a vibrating capsule to restore the colon’s natural rhythm and put you back in control. Clinical results show Vibrant provides one, two and sometimes three additional complete spontaneous bowel movements weekly, even in severe adult patients, with just 1.2% of patients reporting diarrhea. Since Vibrant’s not a drug, there are no interactions with other drugs, unlike traditional and prescription laxatives. Learn more at vibrantgastro.com.

Gallery of images available here

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4adeb8c0-4a0a-44ea-9157-d20e79c5f696

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Best Early Stage Presale Opportunity: Pepe Dollar Shines Against PEPETO in Q3 2026

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

High-Field Variable NMRD Now on the Laboratory Benchtop: Stelar and HTS-110 Launch the 3Tracer 2.0

National Academy of Inventors Convenes Global Leaders in Science, Technology, and Innovation for Landmark 15th Annual Conference in Los Angeles

Rent Wardrobe, Fridge and Study Table in Pune Instead of Buying in 2026 as ₹50,000 Home Setup Costs Push IT-Corridor Tenants Toward ₹2,199/Month Plans From Rentomojo

Crestpoint Real Estate Investments, Vestcor & Anthem Properties Break Ground on King + Park, the New Masterplan Development at The Gateway to Burnaby

Ethereum Meme Coin Little Pepe (LILPEPE) Nearly Sells Out Presale, Tops $28 Million Raised

ZetaChain: The Private Memory Layer for AI

Monument Reports Third Quarter Fiscal 2026 Results

Editors Picks

Saskatchewan receives D+ for addressing poverty

June 1, 2026

New documents show potential pipeline routes from Alberta to B.C.’s coast

June 1, 2026

Gemini’s new AI agent is about as good as Google’s demo

June 1, 2026

Best Early Stage Presale Opportunity: Pepe Dollar Shines Against PEPETO in Q3 2026

June 1, 2026

Latest News

Toronto police charge 5 with antisemitic hate over Bathurst-Sheppard protests

June 1, 2026

This could be Windows’ M1 moment — but expect it to cost a ton

June 1, 2026

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

June 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version